BIO-PSYCHO-SPIRITUAL PERSPECTIVES ON PSYCHEDELICS clinical and ethical implications

被引:3
|
作者
Neitzke-spruill, Logan [1 ]
Devenot, Nese [2 ]
Sisti, Dominic [3 ]
Averill, Lynnette a. [4 ]
McGuire, Amy l. [1 ]
机构
[1] Baylor Coll Med, Ctr Med Eth & Hlth Policy, 1 Baylor Plaza, Houston, TX 77030 USA
[2] Univ Writing Program, Johns Hopkins Krieger Sch Arts & Sci, Baltimore, MD USA
[3] Univ Penn, Dept Med Eth & Hlth Policy, Perelman Sch Med, Philadelphia, PA USA
[4] Baylor Coll Med, Dept Psychiat, Houston, TX USA
关键词
MYSTICAL-TYPE EXPERIENCES; LIFE-THREATENING CANCER; PSILOCYBIN; HALLUCINOGENS; DEPRESSION; RECEPTOR; BRAIN; SELF; SET; DECREASES;
D O I
10.1353/pbm.2024.a919715
中图分类号
N09 [自然科学史]; B [哲学、宗教];
学科分类号
01 ; 0101 ; 010108 ; 060207 ; 060305 ; 0712 ;
摘要
Psychedelics have again become a subject of widespread interest, owing to the reinvigoration of research into their traditional uses, possible medical applications, and social implications. As evidence for psychedelics' clinical potential mounts, the field has increasingly focused on searching for mechanisms to explain the effects of psychedelics and therapeutic efficacy of psychedelic -assisted therapy (PAT). This paper reviews three general frameworks that encompass several prominent models for understanding psychedelics' effects-specifically, neurobiological, psychological, and spiritual frameworks. Following our review, the implications of each framework for ethics and professional competencies in the implementation of psychedelics as medicines are explored. We suggest that interdisciplinary education may be necessary to improve communication between researchers, develop models that effectively incorporate multiple levels of analysis, and facilitate collaboration between professionals with diverse backgrounds in the implementation of psychedelic medicines. We also address pitfalls associated with overemphasis on neuro-mechanisms, risks associated
引用
收藏
页码:117 / 142
页数:27
相关论文
共 50 条